LRMR - Larimar Therapeutics Inc logo

LRMR

Larimar Therapeutics Inc

Rev β€”top 1%10Y
Hold

Larimar Therapeutics develops treatments for rare diseases using its cell-penetrating peptide technology. Its lead candidate, CTI-1601, is in Phase 2 trials for Friedreich’s ataxia, a progressive disease with limited treatment options.

βš•οΈ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago β†’$113today

Score Overview

1 Year
Scoreβ€”
Net Growth-4.18%
Net TrendShrank
Net Income Consistencyβ€”
Rev Growthβ€”
Rev TrendShrank
Revenue Consistencyβ€”
5 Years
Scoreβ€”
Net Growth-243.08%
Net Trend20%
Net Income Consistencyβ€”
Rev Growthβ€”
Rev TrendNever
Revenue Consistencyβ€”
10 Years
Scoreβ€”
Net Growth-198.22%
Net Trend30%
Net Income Consistency
Rev Growthβ€”
Rev TrendNever
Revenue Consistency
All Time
Scoreβ€”
Net Growth-371.99%
Net Trend33%
Net Income Consistency
Rev Growthβ€”
Rev TrendNever
Revenue Consistency

See the full market ranking β†’

Larimar Therapeutics Inc fundamental performance

Across Larimar Therapeutics Inc's full reported history, from 2014 to 2025, net income went from -$ 36M to -$ 165M. Revenue increased in 0% of the years measured; net income in 33%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.37β€”
1 Year2025-08-12
$ 3.7018.11%
5 Years2021-08-12
$ 12.98-66.33%
10 Years2016-08-12
$ 38.76-88.73%
All Time2014-06-19
$ 237.00-98.16%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 172M$ 156M
2025$ 0.00-$ 165M$ 136M
2024$ 0.00-$ 80M$ 183M
2023$ 0.00-$ 36M$ 86M
2022$ 0.00-$ 34M$ 118M
2021$ 0.00-$ 50M$ 70M
2020$ 0.00-$ 42M$ 92M
2019$ 0.00-$ 23M$ 1M
2018-$ 61M$ 118M
2017-$ 52M$ 102M
2016-$ 57M$ 129M
2015-$ 74M$ 185M
IPO2014-$ 36M$ 115M

Explore beyond LRMR

You're looking at Larimar Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies